Alka Redkar
- Geriatrics and Gerontology top 10%
- Biomaterials top 10%
-
- Cancer-related Molecular Pathways 4
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
-
- Force Microscopy Techniques and Applications 2
-
- Pluripotent Stem Cells Research 2
- Cancer therapeutics and mechanisms 2
- Cell death mechanisms and regulation 2
- Co-authors
- Jianhua CuiStephen F. BadylakKeith A. RobinsonRobert G. MathenyMegumi MathisonNicolas A.F. ChronosIndraneel MittraGary G. Meadows
- Journals
- British Journal of Cancer (2 papers)Cytometry (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- IndiaUnited StatesGermany
In The Last Decade
Alka Redkar
23 papers receiving 635 citations
Peers
Comparison fields: 5 of 90
- Geriatrics and Gerontology 50
- Biomaterials 152
- Cardiology and Cardiovascular Medicine 121
- Surgery 198
- Biochemistry 25
Countries citing papers authored by Alka Redkar
This map shows the geographic impact of Alka Redkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alka Redkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alka Redkar more than expected).
Fields of papers citing papers by Alka Redkar
This network shows the impact of papers produced by Alka Redkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alka Redkar. The network helps show where Alka Redkar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alka Redkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 10 | |
| 2 | 2005 | 176 | |
| 3 | 2003 | 121 | |
| 4 | 2001 | 3 | |
| 5 | 2001 | 5 | |
| 6 | The malignant transformation of Syrian hamster embryo [SHE] cells in primary culture by malachite green: the transformation is associated with enhanced vimentin phosphorylation, PCNA expression and BrdU incorporation | 2000 | 3 |
| 7 | 2000 | 80 | |
| 8 | 2000 | 39 | |
| 9 | 2000 | 12 | |
| 10 | 1999 | 35 | |
| 11 | Malignant transformation of Syrian hamster embryo (SHE) cells in culture by malachite green: an agent of environmental importance. | 1999 | 24 |
| 12 | 1998 | 17 | |
| 13 | 1998 | 12 | |
| 14 | 1997 | 16 | |
| 15 | 1996 | 8 | |
| 16 | 1995 | 24 | |
| 17 | Prognostic significance of DNA index by flowcytometry in acute lymphoblastic leukaemia. | 1995 | 2 |
| 18 | 1994 | 6 | |
| 19 | 1993 | 28 | |
| 20 | 1992 | 5 |
About Alka Redkar
Alka Redkar is a scholar working on Transplantation, Oncology, Cancer Research, Geriatrics and Gerontology and Immunology, having authored 24 papers that have together received 661 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Force Microscopy Techniques and Applications (2 papers), Pluripotent Stem Cells Research (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Cells and Metastasis (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Geriatrics and Gerontology (50 citations), Biomaterials (152 citations), Cardiology and Cardiovascular Medicine (121 citations), Surgery (198 citations) and Biochemistry (25 citations). Alka Redkar has collaborated with scholars based in India, United States and Germany. Frequent co-authors include Jianhua Cui, Stephen F. Badylak, Keith A. Robinson, Robert G. Matheny, Megumi Mathison, Nicolas A.F. Chronos, Indraneel Mittra, Gary G. Meadows, Richard M. Niles and Margaret McFarland. Their work appears in journals such as British Journal of Cancer, Cytometry, International Journal of Oncology, Cancer and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.